Farther Finance Advisors, LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in HALO

as of Mar 31, 2026 · filed Apr 7, 2026 Compact

Position Value

$861,711

+$26,182 QoQ

Shares Held

13,333

+7.4% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Farther Finance Advisors, LLC holds $14,686,998 across 278 Biotechnology names. HALO ranks #5 (5.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,752	$2,121,958
2	REGN	Regeneron Pharmaceuticals, Inc.	1,870	$1,444,836
3	MRNA	Moderna, Inc.	20,211	$1,026,718
4	SMMT	Summit Therapeutics Inc.	50,316	$953,991
5	HALO	Halozyme Therapeutics, Inc. This page	13,333	$861,711
6	ARWR	Arrowhead Pharmaceuticals, Inc.	11,971	$750,581
7	EXEL	Exelixis, Inc.	16,443	$705,240
8	BMRN	Biomarin Pharmaceutical Inc	7,857	$443,841

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$861,711	13,333	+7.4%	Shares	Sole	2026-04-07
2025-12-31	$835,529	12,415	+7.5%	Shares	Sole	2026-01-23
2025-09-30	$847,370	11,554	+32.5%	Shares	Sole	2025-10-14
2025-06-30	$453,718	8,722	+58.4%	Shares	Sole	2025-07-11
2025-03-31	$351,274	5,505	+620.5%	Shares	Sole	2025-04-14
2024-12-31	$36,526	764	-52.8%	Shares	Sole	2025-02-10
2024-09-30	$92,728	1,620	+173.6%	Shares	Sole	2024-10-29
2024-06-30	$30,997	592	+332.1%	Shares	Sole	2024-07-31
2024-03-31	$5,573	137	-45.8%	Shares	Sole	2024-05-14
2023-12-31	$9,350	253	+743.3%	Shares	Sole	2024-02-15
2023-09-30	$1,146	30	0.0%	Shares	Sole	2023-11-14
2023-06-30	$1,082	30	+500.0%	Shares	Sole	2024-05-14
2023-03-31	$190	5	—	Shares	Sole	2024-05-14
No filing history on record for this holder in this stock.